000 01485 a2200421 4500
005 20250515064204.0
264 0 _c20070613
008 200706s 0 0 eng d
022 _a1352-4585
024 7 _a10.1177/1352458506071172
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDi Rezze, S
245 0 0 _aAn exploratory study on interferon beta dose effect in reducing size of enhancing lesions in multiple sclerosis.
_h[electronic resource]
260 _bMultiple sclerosis (Houndmills, Basingstoke, England)
_cApr 2007
300 _a343-7 p.
_bdigital
500 _aPublication Type: Journal Article; Randomized Controlled Trial
650 0 4 _aAdjuvants, Immunologic
_xtherapeutic use
650 0 4 _aAdult
650 0 4 _aAge of Onset
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aFemale
650 0 4 _aFollow-Up Studies
650 0 4 _aHumans
650 0 4 _aInjections, Subcutaneous
650 0 4 _aInterferon beta-1a
650 0 4 _aInterferon-beta
_xadministration & dosage
650 0 4 _aMagnetic Resonance Imaging
650 0 4 _aMale
650 0 4 _aMultiple Sclerosis
_xdrug therapy
650 0 4 _aTime Factors
700 1 _aGupta, S
700 1 _aDurastanti, V
700 1 _aMillefiorini, E
700 1 _aPozzilli, C
700 1 _aBagnato, F
773 0 _tMultiple sclerosis (Houndmills, Basingstoke, England)
_gvol. 13
_gno. 3
_gp. 343-7
856 4 0 _uhttps://doi.org/10.1177/1352458506071172
_zAvailable from publisher's website
999 _c16990151
_d16990151